-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Data Worth Stopping For: New 5-year Follow-Up Data for an Oral-Based CLL Regimen with a Fixed Treatment Duration

Sponsor: AbbVie
Program: Product Theaters
Saturday, December 10, 2022: 11:30 AM-12:30 PM
Hall J - Theater 1 (Ernest N. Morial Convention Center)
Ahmed Kotb, MD, AbbVie
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters